173 related articles for article (PubMed ID: 28683183)
1. PEGylated Dendritic Polyglycerol Conjugate Delivers Doxorubicin to the Parasitophorous Vacuole in Leishmania infantum Infections.
Gutierrez-Corbo C; Dominguez-Asenjo B; Vossen LI; Pérez-Pertejo Y; Muñoz-Fenández MA; Balaña-Fouce R; Calderón M; Reguera RM
Macromol Biosci; 2017 Oct; 17(10):. PubMed ID: 28683183
[TBL] [Abstract][Full Text] [Related]
2. In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio.
Baabur-Cohen H; Vossen LI; Krüger HR; Eldar-Boock A; Yeini E; Landa-Rouben N; Tiram G; Wedepohl S; Markovsky E; Leor J; Calderón M; Satchi-Fainaro R
J Control Release; 2017 Jul; 257():118-131. PubMed ID: 27374630
[TBL] [Abstract][Full Text] [Related]
3. Legumain-cleavable 4-arm poly(ethylene glycol)-doxorubicin conjugate for tumor specific delivery and release.
Zhou H; Sun H; Lv S; Zhang D; Zhang X; Tang Z; Chen X
Acta Biomater; 2017 May; 54():227-238. PubMed ID: 28315495
[TBL] [Abstract][Full Text] [Related]
4. Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Oct; 30(29):5757-66. PubMed ID: 19643472
[TBL] [Abstract][Full Text] [Related]
5. Mannose-Decorated Dendritic Polyglycerol Nanocarriers Drive Antiparasitic Drugs To
Vossen LI; Domínguez-Asenjo B; Gutiérrez-Corbo C; Pérez-Pertejo MY; Balaña-Fouce R; Reguera RM; Calderón M
Pharmaceutics; 2020 Sep; 12(10):. PubMed ID: 32987800
[TBL] [Abstract][Full Text] [Related]
6. Modular approach for theranostic polymer conjugates with activatable fluorescence: Impact of linker design on the stimuli-induced release of doxorubicin.
Nagel G; Tschiche HR; Wedepohl S; Calderón M
J Control Release; 2018 Sep; 285():200-211. PubMed ID: 30005907
[TBL] [Abstract][Full Text] [Related]
7. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.
Dong DW; Xiang B; Gao W; Yang ZZ; Li JQ; Qi XR
Biomaterials; 2013 Jul; 34(20):4849-59. PubMed ID: 23541420
[TBL] [Abstract][Full Text] [Related]
8. pH-Responsive therapeutic solid lipid nanoparticles for reducing P-glycoprotein-mediated drug efflux of multidrug resistant cancer cells.
Chen HH; Huang WC; Chiang WH; Liu TI; Shen MY; Hsu YH; Lin SC; Chiu HC
Int J Nanomedicine; 2015; 10():5035-48. PubMed ID: 26346762
[TBL] [Abstract][Full Text] [Related]
9. A tumor-specific cleavable nanosystem of PEG-modified C60@Au hybrid aggregates for radio frequency-controlled release, hyperthermia, photodynamic therapy and X-ray imaging.
Shi J; Chen Z; Wang L; Wang B; Xu L; Hou L; Zhang Z
Acta Biomater; 2016 Jan; 29():282-297. PubMed ID: 26485168
[TBL] [Abstract][Full Text] [Related]
10. Development and evaluation of pH-responsive single-walled carbon nanotube-doxorubicin complexes in cancer cells.
Gu YJ; Cheng J; Jin J; Cheng SH; Wong WT
Int J Nanomedicine; 2011; 6():2889-98. PubMed ID: 22131835
[TBL] [Abstract][Full Text] [Related]
11. Imaging of doxorubicin release from theranostic macromolecular prodrugs via fluorescence resonance energy transfer.
Krüger HR; Schütz I; Justies A; Licha K; Welker P; Haucke V; Calderón M
J Control Release; 2014 Nov; 194():189-96. PubMed ID: 25176577
[TBL] [Abstract][Full Text] [Related]
12. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.
Xu M; Qian J; Liu X; Liu T; Wang H
Mater Sci Eng C Mater Biol Appl; 2015 May; 50():341-7. PubMed ID: 25746279
[TBL] [Abstract][Full Text] [Related]
13. Polyglycerol-coated nanodiamond as a macrophage-evading platform for selective drug delivery in cancer cells.
Zhao L; Xu YH; Akasaka T; Abe S; Komatsu N; Watari F; Chen X
Biomaterials; 2014 Jul; 35(20):5393-5406. PubMed ID: 24720879
[TBL] [Abstract][Full Text] [Related]
14. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
[TBL] [Abstract][Full Text] [Related]
15. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J
Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117
[TBL] [Abstract][Full Text] [Related]
16. Development of nanocapsules bearing doxorubicin for macrophage targeting through the phosphatidylserine ligand: a system for intervention in visceral leishmaniasis.
Kansal S; Tandon R; Dwivedi P; Misra P; Verma PR; Dube A; Mishra PR
J Antimicrob Chemother; 2012 Nov; 67(11):2650-60. PubMed ID: 22872448
[TBL] [Abstract][Full Text] [Related]
17. HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity.
Ulbrich K; Etrych T; Chytil P; Jelínková M; Ríhová B
J Control Release; 2003 Feb; 87(1-3):33-47. PubMed ID: 12618021
[TBL] [Abstract][Full Text] [Related]
18. Amphiphilic polycarbonate conjugates of doxorubicin with pH-sensitive hydrazone linker for controlled release.
Jiang T; Li YM; Lv Y; Cheng YJ; He F; Zhuo RX
Colloids Surf B Biointerfaces; 2013 Nov; 111():542-8. PubMed ID: 23893028
[TBL] [Abstract][Full Text] [Related]
19. The potential of self-assembled, pH-responsive nanoparticles of mPEGylated peptide dendron-doxorubicin conjugates for cancer therapy.
She W; Luo K; Zhang C; Wang G; Geng Y; Li L; He B; Gu Z
Biomaterials; 2013 Feb; 34(5):1613-23. PubMed ID: 23195490
[TBL] [Abstract][Full Text] [Related]
20. Comparative studies of polyethylenimine-doxorubicin conjugates with pH-sensitive and pH-insensitive linkers.
Dong DW; Tong SW; Qi XR
J Biomed Mater Res A; 2013 May; 101(5):1336-44. PubMed ID: 23065848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
